Psychemedics (Psychemedics) Retained Earnings : $-16.77 Mil (As of Dec. 2023)

View and export this data going back to 1987. Start your Free Trial

What is Psychemedics Retained Earnings?

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. Psychemedics's retained earnings for the quarter that ended in Dec. 2023 was $-16.77 Mil.

Psychemedics's quarterly retained earnings declined from Jun. 2023 ($-13.73 Mil) to Sep. 2023 ($-15.83 Mil) and declined from Sep. 2023 ($-15.83 Mil) to Dec. 2023 ($-16.77 Mil).

Psychemedics's annual retained earnings declined from Dec. 2021 ($-9.55 Mil) to Dec. 2022 ($-11.82 Mil) and declined from Dec. 2022 ($-11.82 Mil) to Dec. 2023 ($-16.77 Mil).

Psychemedics Retained Earnings Historical Data

The historical data trend for Psychemedics's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Psychemedics Retained Earnings Chart

Psychemedics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Retained Earnings

Get a 7-Day Free Trial

-3.75

-8.61

-9.55

-11.82

-16.77

Psychemedics Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Retained Earnings	Get a 7-Day Free Trial															-11.82	-12.60	-13.73	-15.83	-16.77

Psychemedics Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.

Psychemedics (NAS:PMD) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.

Psychemedics (Psychemedics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Psychemedics Corp (NAS:PMD) » Definitions » Retained Earnings

Comparable Companies

Traded in Other Exchanges

N/A

Address

289 Great Road, Suite 200, Acton, MA, USA, 01720

Website

https://www.psychemedics.com

Psychemedics Corp is engaged in providing testing services for the detection of drugs of abuse through the analysis of hair samples. The company operates through a single segment of drug testing services which include training for the collection of samples and storage of positive samples for its customers for an agreed-upon fee per unit testing of samples. The testing methods of the company utilize a patented technology that digests the hair and releases drugs trapped in the hair without destroying the drugs. Geographically it generates the majority of its revenue from the United States.

Executives

Shannon Shoemaker	officer: Chief Revenue Officer	289 GREAT ROAD, SUITE 200, ACTON MA 01720
Charles M Doucot	officer: Executive Vice President	289 GREAT ROAD, SUITE 200, ACTON MA 01720
Andrew Reynolds	director	C/O FLEETMATICS, 1100 WINTER STREET, 4TH FL, WALTHAM MA 02451
Brian Hullinger	director, officer: President & CEO	289 GREAT ROAD, SUITE 200, ACTON MA 01720
Robyn C Davis	director	ONE WALLINGFORD ROAD, MARBLEHEAD MA 01945
Michael Weisenhoff	other: Assistant Controller	289 GREAT ROAD, SUITE 200, ACTON MA 01720
Michael I Schaffer	officer: VP of Laboratory Operations	C/O PAYCHEMEDICS CORP, 1280 MASSACHUSETTS AVE STE 200, CAMBRIDGE MA 02138
William B. Norris	other: Assistant Controller	289 GREAT ROAD, SUITE 200, ACTON MA 01720
Darius G Nevin	other: See Footnote 1	C/O WCI COMMUNITIES, INC., 24301 WALDEN CENTER DRIVE, BONITA SPRINGS FL 34134
Peter H Kamin	10 percent owner	2720 DONALD ROSS ROAD, #311, PALM BEACH GARDENS FL 33410
Andrew Limbek	officer: Vice President & Controller	289 GREAT ROAD, SUITE 200, ACTON MA 01720
Fred J Weinert	director	330 E MAIN ST, BARRINGTON IL 60620
Kubacki Raymond C Jr	director, officer: Chairman, CEO & President	125 NAGOG PARK, ACTON MA 01720
A Clinton Allen	director, officer: Chairman	1280 MASSACHUSETTS AVE STE 200, CAMBRIDGE MA 02138
Neil Lerner	officer: VP - Finance	C/O PSYCHEMEDICS CORPORATION, 125 NAGOG PARK, ACTON MA 01720